Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 20
Filter
1.
Microb Biotechnol ; 15(2): 590-602, 2022 02.
Article in English | MEDLINE | ID: mdl-34156757

ABSTRACT

Biofilms are communities of bacteria, fungi or yeasts that form on diverse biotic or abiotic surfaces, and play important roles in pathogenesis and drug resistance. A generic saw palmetto oil inhibited biofilm formation by Staphylococcus aureus, Escherichia coli O157:H7 and fungal Candida albicans without affecting their planktonic cell growth. Two main components of the oil, lauric acid and myristic acid, are responsible for this antibiofilm activity. Their antibiofilm activities were observed in dual-species biofilms as well as three-species biofilms of S. aureus, E. coli O157:H7 and C. albicans. Transcriptomic analysis showed that lauric acid and myristic acid repressed the expressions of haemolysin genes (hla and hld) in S. aureus, several biofilm-related genes (csgAB, fimH and flhD) in E. coli and hypha cell wall gene HWP1 in C. albicans, which supported biofilm inhibition. Also, saw palmetto oil, lauric acid and myristic acid reduced virulence of three microbes in a nematode infection model and exhibited minimal cytotoxicity. Furthermore, combinatorial treatment of fatty acids and antibiotics showed synergistic antibacterial efficacy against S. aureus and E. coli O157:H7. These results demonstrate that saw palmetto oil and its main fatty acids might be useful for controlling bacterial infections as well as multispecies biofilms.


Subject(s)
Escherichia coli O157 , Staphylococcus aureus , Anti-Bacterial Agents/pharmacology , Biofilms , Candida albicans , Lauric Acids/pharmacology , Myristic Acid/pharmacology , Plant Extracts , Serenoa
2.
J Sep Sci ; 43(8): 1566-1575, 2020 Apr.
Article in English | MEDLINE | ID: mdl-32053742

ABSTRACT

Phenyl myristate was isolated from Homalium nepalense, which is known for its therapeutic virtues in traditional medicine. However, the study of radical scavenging-capacity of phenyl myristate is limited by its relatively low abundance in medicinal plants. We have studied the isolation, structure-elucidation, and bioactivities of high-performance thin-layer chromatography validated phenyl myristate from hydroalcohol-extract of bark of H. nepalense. The chemical structure of phenyl myristate was elucidated by spectroscopic methods. The chromatography was performed on high-performance thin-layer chromatography aluminum plates coated with silica-gel 60 F254 . Determination and quantitation of phenyl myristate were performed by densitometric-scanning at 254 nm (chloroform-methanol, 9:1, v/v; Rf 0.49). The method was validated according to International Council for Harmonisation guidelines in terms of linearity, specificity, sensitivity, accuracy, precision, robustness, and stability. Linearity-range of phenyl myristate was 100-500 ng/5 µL with correlation-coefficient r2  = 0.9997. Limits of detection and quantitation were 3.35 and 10.17 ng, respectively. Phenyl myristate showed significant free-radical-scavenging activities in 2,2-diphenyl-1-picrylhydrazyl, oxygen-radical-absorbance-capacity, and ex vivo cell-based-antioxidant-protection-in-erythrocytes assays. Molecular-docking approach of phenyl myristate showed effective binding at active sites of human serum albumin (HSA) with the lowest binding energy (-8.4 kcal/mol) that was comparable with ascorbic acid (-5.0 kcal/mol). These studies provide mechanistic insight into the potential free radical scavenging activities of phenyl myristate.


Subject(s)
Free Radical Scavengers/analysis , Molecular Docking Simulation , Myristic Acid/analysis , Plant Extracts/analysis , Salicaceae/chemistry , Biphenyl Compounds/antagonists & inhibitors , Chromatography, Thin Layer , Erythrocytes/drug effects , Free Radical Scavengers/pharmacology , Humans , Molecular Structure , Myristic Acid/pharmacology , Picrates/antagonists & inhibitors , Plant Extracts/pharmacology
3.
Sci Rep ; 9(1): 14926, 2019 10 17.
Article in English | MEDLINE | ID: mdl-31624310

ABSTRACT

Deep eutectic solvents have been recently reported as an interesting alternative to improve the therapeutic efficacy of conventional drugs, hence called therapeutic deep eutectic solvents (THEDES). The main objective of this work was to evaluate the potential of limonene (LIM) based THEDES as new possible systems for cancer treatment. LIM is known to have antitumor activity, however it is highly toxic and cell viability is often compromised, thus this compound is not selective towards cancer cells. Different THEDES based on LIM were developed to unravel the anticancer potential of such systems. THEDES were prepared by gently mixing saturated fatty acids menthol or ibuprofen (IBU) with LIM. Successful THEDES were obtained for Menthol:LIM (1:1), CA:LIM (1:1), IBU:LIM (1:4) and IBU:LIM(1:8). The results indicate that all the THEDES present antiproliferative properties, but IBU:LIM (1:4) was the only formulation able to inhibit HT29 proliferation without comprising cell viability. Therefore, IBU:LIM (1:4) was the formulation selected for further assessment of anticancer properties. The results suggest that the mechanism of action of LIM:IBU (1:4) is different from isolated IBU and LIM, which suggest the synergetic effect of DES. In this work, we unravel a methodology to tune the selectivity of LIM towards HT29 cell line without compromising cell viability of healthy cells. We demonstrate furthermore that coupling LIM with IBU leads also to an enhancement of the anti-inflammatory activity of IBU, which may be important in anti-cancer therapies.


Subject(s)
Antineoplastic Agents/pharmacology , Cell Proliferation/drug effects , Ionic Liquids/pharmacology , Limonene/pharmacology , Neoplasms/drug therapy , Antineoplastic Agents/chemistry , Antineoplastic Agents/therapeutic use , Caco-2 Cells , Cell Survival/drug effects , Decanoic Acids/chemistry , Decanoic Acids/pharmacology , Decanoic Acids/therapeutic use , Drug Compounding/methods , Drug Screening Assays, Antitumor , HT29 Cells , Humans , Ibuprofen/chemistry , Ibuprofen/pharmacology , Ibuprofen/therapeutic use , Ionic Liquids/chemistry , Ionic Liquids/therapeutic use , Limonene/chemistry , Limonene/therapeutic use , Menthol/chemistry , Menthol/pharmacology , Menthol/therapeutic use , Myristic Acid/chemistry , Myristic Acid/pharmacology , Myristic Acid/therapeutic use , Neoplasms/pathology
4.
J Antibiot (Tokyo) ; 72(5): 298-305, 2019 05.
Article in English | MEDLINE | ID: mdl-30787402

ABSTRACT

Listeria monocytogenes (L. monocytogenes), an important food-borne pathogenic microorganism, has resistance immune function to many commonly used drugs. Myristic acid is a traditional Chinese herbal medicine, but it has been rarely used as a food additive, limiting the development of natural food preservatives. In this study, the antibacterial activity and mechanism of myristic acid against L. monocytogenes were studied. The minimum inhibitory concentration (MIC) of myristic acid against 13 L. monocytogenes strains ranged from 64 to 256 µg ml-1. The time-kill assay demonstrated that when myristic acid was added to dairy products, flow cytometry confirmed that myristic acid influenced cell death and inhibited the growth of L. monocytogenes. Transmission electron microscopy (TEM), scanning electron microscopy (SEM), and NPN uptake studies illustrated that myristic acid changed the bacterial morphology and membrane structure of L. monocytogenes, which led to rapid cell death. Myristic acid could bind to DNA and lead to changes in DNA conformation and structure, as identified by fluorescence spectroscopy. Our studies provide additional evidence to support myristic acid being used as a natural antibacterial agent and also further fundamental understanding of the modes of antibacterial action.


Subject(s)
Anti-Bacterial Agents/pharmacology , Listeria monocytogenes/drug effects , Milk/microbiology , Myristic Acid/pharmacology , Animals , Cell Membrane/drug effects , Disease Transmission, Infectious , Flow Cytometry , Listeria monocytogenes/cytology , Listeria monocytogenes/growth & development , Listeria monocytogenes/physiology , Microbial Sensitivity Tests , Microbial Viability/drug effects , Microscopy, Electron, Scanning , Microscopy, Electron, Transmission , Nucleic Acid Conformation/drug effects , Spectrometry, Fluorescence
5.
J Ethnopharmacol ; 194: 981-986, 2016 Dec 24.
Article in English | MEDLINE | ID: mdl-27794508

ABSTRACT

AIM OF THE STUDY: Pleopeltis polylepis (Polypodaceae) is a fern used in the traditional Mexican medicine to treat fever, bleeding, typhoid, cough, pertussis, chest pain, and renal and hepatic diseases. The aim of this study was to analyze the bioactivities of different extracts, fractions and isolated compounds from this species to scientifically validate its medicinal applications. MATERIALS AND METHODS: Aerial parts of P. polylepis were macerated and extracted consecutively with hexane, chloroform, and methanol. These extracts were subsequently fractionated and compounds from hexane and methanol extracts were purified. The antimicrobial activity was assessed using a panel of eight Gram-positive and -negative bacterial and four fungal strains. The cytotoxicity of the compounds was assessed by flow cytometry using propidium iodide and the human-derived monocytic cell line THP-1. The anti-inflammatory activity was investigated by measuring the secretion of interleukin-6 and IL-10 using also the cell line THP-1. RESULTS: Various extracts, fractions and compounds obtained from this plant showed antibacterial activity against both Gram-positive and -negative strains. Antifungal activity was confirmed only in Candida albicans and Tricophyton mentagrophytes. Two fractions and two isolated compounds (butyl myristate and ß-sitosterol) showed no significant cytotoxicity and were further evaluated for their anti-inflammatory activity. All four samples tested showed an anti-inflammatory activity similar to prednisone used as a control. CONCLUSIONS: The benefit of P. polylepis as a traditional plant related to its antimicrobial and anti-inflammatory activities was confirmed by in vitro assays. To the best of our knowledge, this is the first study reporting the isolation and bioactivities of extracts, fractions or isolated compounds from P. polylepis.


Subject(s)
Anti-Infective Agents/pharmacology , Anti-Inflammatory Agents/pharmacology , Cytotoxins/pharmacology , Plant Extracts/pharmacology , Polypodiaceae/chemistry , Anti-Infective Agents/chemistry , Anti-Inflammatory Agents/chemistry , Cell Line , Cytotoxins/chemistry , Fungi/drug effects , Gram-Negative Bacteria/drug effects , Gram-Positive Bacteria/drug effects , Humans , Interleukin-10/metabolism , Interleukin-6/metabolism , Medicine, Traditional , Mexico , Myristic Acid/chemistry , Myristic Acid/pharmacology , Plant Extracts/chemistry , Sitosterols/chemistry , Sitosterols/pharmacology
6.
Pharm Biol ; 54(12): 2814-2821, 2016 Dec.
Article in English | MEDLINE | ID: mdl-27307092

ABSTRACT

CONTEXT: The bulb of Allium sativum Linn (Alliaceae) has numerous medicinal values. Though the petroleum ether extract of the bulb has shown to exhibit antimycobacterial activity, the phytochemical(s) responsible for this inhibitory activity is not known. OBJECTIVE: To characterize the bioactive compounds in the petroleum ether extract of Allium sativum (garlic) that inhibit the growth of Mycobacterium tuberculosis H37Ra. MATERIALS AND METHODS: Bioactivity-guided fractionation was employed to isolate the bioactive compounds. Antimycobacterial activity was evaluated by well-diffusion method and microplate alamar blue assay (MABA). Infrared spectroscopy, mass spectrometry and nuclear magnetic resonance spectroscopy were used to characterize the bioactive compounds. Autodock was used to obtain information on molecular recognition, and molecular dynamics simulation was performed using GROMACS. RESULTS: The bioactive compounds that inhibited the growth of M. tuberculosis H37Ra were found to be lauric acid (LA) and myristic acid (MA). The minimal inhibitory concentration of LA and MA was found to be 22.2 and 66.7 µg/mL, respectively. In silico analysis revealed that these fatty acids could bind at the cleft between the N-terminal and C-terminal lobes of the cytosolic domain of serine/threonine protein kinase B (PknB). DISCUSSION AND CONCLUSION: The inhibition activity was dependent on the alkyl chain length of the fatty acid, and the amino acid residues involved in binding to fatty acid was found to be conserved across the Pkn family of proteins. The study indicates the possibility of using fatty acid derivatives, involving Pkn family of proteins, to inhibit the signal transduction processes in M. tuberculosis.


Subject(s)
Garlic , Lauric Acids/metabolism , Mycobacterium tuberculosis/metabolism , Myristic Acid/metabolism , Plant Extracts/metabolism , Proto-Oncogene Proteins c-akt/metabolism , Antitubercular Agents/isolation & purification , Antitubercular Agents/metabolism , Antitubercular Agents/pharmacology , Computer Simulation , Humans , Lauric Acids/isolation & purification , Lauric Acids/pharmacology , Mycobacterium tuberculosis/drug effects , Mycobacterium tuberculosis/growth & development , Myristic Acid/isolation & purification , Myristic Acid/pharmacology , Plant Extracts/isolation & purification , Plant Extracts/pharmacology , Plant Roots , Protein Binding/physiology , Protein Structure, Secondary , Protein Structure, Tertiary , Proto-Oncogene Proteins c-akt/chemistry
7.
J Oleo Sci ; 63(12): 1243-50, 2014.
Article in English | MEDLINE | ID: mdl-25391685

ABSTRACT

Nowadays, data concerning the composition of Caryodendron orinocense Karst. (Euphorbiaceae) and Bactris gasipaes Kunth (Arecaceae) seed oils are lacking. In light of this fact, in this paper fatty acids and unsaponifiable fraction composition have been determined using GC-MS, HPLC-DAD (Diode Array Detector), NMR approaches and possible future applications have been preliminary investigated through estimation of antioxidant activity, performed with DPPH test. For C. orinocense linoleic acid (85.59%) was the main component, lauric (33.29%) and myristic (27.76%) acids were instead the most abundant in B. gasipaes. C. orinocense unsaponifiable fraction (8.06%) evidenced a remarkable content of ß-sitosterol, campesterol, stigmasterol, squalene and vitamin E (816 ppm). B. gasipaes revealed instead ß-sitosterol and squalene as main constituents of unsaponifiable matter (3.01%). Antioxidant capacity evidenced the best performance of C. orinocense seed oil. These preliminary results could be interesting to suggest the improvement of the population's incomes from Amazonian basin. In particular the knowledge of chemical composition of C. orinocense and B. gasipaes oils could be helpful to divulge and valorize these autochthones plants.


Subject(s)
Antioxidants , Arecaceae/chemistry , Euphorbiaceae/chemistry , Fatty Acids/isolation & purification , Fatty Acids/pharmacology , Nuts/chemistry , Plant Oils/chemistry , Seeds/chemistry , Cholesterol/analogs & derivatives , Cholesterol/analysis , Cholesterol/isolation & purification , Cholesterol/pharmacology , Chromatography, High Pressure Liquid , Fatty Acids/analysis , Free Radical Scavengers , Gas Chromatography-Mass Spectrometry , Lauric Acids/analysis , Lauric Acids/isolation & purification , Lauric Acids/pharmacology , Linoleic Acid/analysis , Linoleic Acid/isolation & purification , Linoleic Acid/pharmacology , Magnetic Resonance Spectroscopy , Myristic Acid/analysis , Myristic Acid/isolation & purification , Myristic Acid/pharmacology , Phytosterols/analysis , Phytosterols/isolation & purification , Phytosterols/pharmacology , Plant Oils/isolation & purification , Sitosterols/analysis , Sitosterols/isolation & purification , Sitosterols/pharmacology , Squalene/analysis , Squalene/isolation & purification , Squalene/pharmacology , Stigmasterol/analysis , Stigmasterol/isolation & purification , Stigmasterol/pharmacology , Vitamin E/analysis , Vitamin E/isolation & purification , Vitamin E/pharmacology
8.
Mol Cell Biochem ; 364(1-2): 1-9, 2012 May.
Article in English | MEDLINE | ID: mdl-22198290

ABSTRACT

Natural compounds with free-radical scavenging activity have potential role in maintaining human health and preventing diseases. In this study, we report the antioxidant and cytoprotective properties of 14-aminotetradecanoic acid (ATDA) isolated from the Decalepis hamiltonii roots. ATDA is a potent scavenger of superoxide (O(2) (•-)), hydroxyl ((•)OH), nitric oxide ((•)NO), and lipid peroxide (LOO(•)) physiologically relevant free radicals with IC(50) values in nM (36-323) range. ATDA also exhibits concentration-dependent secondary antioxidant activities like reducing power, metal-chelating activity, and inhibition of protein carbonylation. Further, ATDA at nM concentration prevented CuSO(4)-induced human LDL oxidation. ATDA demonstrated cytoprotective activity in primary hepatocytes and Ehrlich ascites tumor cells against oxidative stress inducing xenobiotics apart from the in vitro free-radical scavenging activity. The mechanism of cytoprotective action involved maintaining the intracellular glutathione, scavenging of reactive oxygen species, and inhibition of lipid peroxidation. It is suggested that ATDA is a novel bioactive molecule with potential health implications.


Subject(s)
Antioxidants/pharmacology , Apocynaceae , Cytoprotection , Free Radical Scavengers/pharmacology , Myristic Acid/pharmacology , Plant Extracts/pharmacology , Animals , Antioxidants/chemistry , Apocynaceae/chemistry , Free Radical Scavengers/chemistry , Glutathione/chemistry , Humans , Hydrogen Peroxide/chemistry , Lipid Peroxidation/drug effects , Microsomes, Liver/drug effects , Myristic Acid/chemistry , Nitric Oxide/chemistry , Oxidative Stress/drug effects , Plant Extracts/chemistry , Plant Roots/chemistry , Protein Carbonylation/drug effects , Rats , Reactive Oxygen Species/chemistry , Superoxides/chemistry , Xenobiotics/toxicity
9.
Indian J Exp Biol ; 49(9): 684-8, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21941942

ABSTRACT

D-004, a lipid extract of Roystonea regia fruits that contains oleic, lauric and myristic acids as major components inhibits alpha1-adrenoreceptors-mediated contractile responses in isolated rat vas deferens and prostate trips; no study has demonstrated a similar effect for oleic, lauric or myristic acids individually. Therefore, the effects of D-004 (250 microg/mL), oleic (100 microg/mL), lauric (50 microg/mL) or myristic (25 microg/mL) acids and their combined effects on phenylephrine (PHE: 10(-7)-10(-4) mol/L) induced contractions has been studied. No treatment changed the basal tone of the preparations, but all inhibited PHE-induced contractions. D-004 produced the highest inhibition, followed by lauric acid, which was more effective than myristic and oleic acids against PHE-induced contractions of control group. D-004 and the mixture of the three acids produced similar inhibitions.


Subject(s)
Adrenergic alpha-1 Receptor Antagonists/pharmacology , Lauric Acids/pharmacology , Muscle Contraction/drug effects , Myristic Acid/pharmacology , Oleic Acid/pharmacology , Vas Deferens/drug effects , Adrenergic alpha-1 Receptor Antagonists/isolation & purification , Animals , Arecaceae , In Vitro Techniques , Lauric Acids/isolation & purification , Male , Muscle, Smooth/drug effects , Myristic Acid/isolation & purification , Oleic Acid/isolation & purification , Phenylephrine/pharmacology , Plant Extracts/isolation & purification , Plant Extracts/pharmacology , Prostatic Hyperplasia/drug therapy , Prostatic Hyperplasia/metabolism , Prostatic Hyperplasia/physiopathology , Rats , Rats, Sprague-Dawley , Vas Deferens/metabolism
10.
J Dairy Sci ; 94(3): 1445-54, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21338809

ABSTRACT

Two experiments were conducted to assess the effects of a mixture of dietary additives on enteric methane production, rumen fermentation, diet digestibility, energy balance, and animal performance in lactating dairy cows. Identical diets were fed in both experiments. The mixture of feed additives investigated contained lauric acid, myristic acid, linseed oil, and calcium fumarate. These additives were included at 0.4, 1.2, 1.5, and 0.7% of dietary dry matter, respectively (treatment ADD). Experimental fat sources were exchanged for a rumen inert source of fat in the control diet (treatment CON) to maintain isolipidic rations. Cows (experiment 1, n=20; experiment 2, n=12) were fed restricted amounts of feed to avoid confounding effects of dry matter intake on methane production. In experiment 1, methane production and energy balance were studied using open-circuit indirect calorimetry. In experiment 2, 10 rumen-fistulated animals were used to measure rumen fermentation characteristics. In both experiments animal performance was monitored. The inclusion of dietary additives decreased methane emissions (g/d) by 10%. Milk yield and milk fat content tended to be lower for ADD in experiment 1. In experiment 2, milk production was not affected by ADD, but milk fat content was lower. Fat- and protein-corrected milk was lower for ADD in both experiments. Milk urea nitrogen content was lowered by ADD in experiment 1 and tended to be lower in experiment 2. Apparent total tract digestibility of fat, but not that of starch or neutral detergent fiber, was higher for ADD. Energy retention did not differ between treatments. The decrease in methane production (g/d) was not evident when methane emission was expressed per kilogram of milk produced. Feeding ADD resulted in increases of C12:0 and C14:0 and the intermediates of linseed oil biohydrogenation in milk in both experiments. In experiment 2, ADD-fed cows tended to have a decreased number of protozoa in rumen fluid when compared with that in control cows. Total volatile fatty acid concentrations were lower for ADD, whereas molar proportions of propionate increased at the expense of acetate and butyrate.


Subject(s)
Cattle/physiology , Diet/veterinary , Digestion/drug effects , Food Additives/pharmacology , Lactation/drug effects , Methane/biosynthesis , Animal Feed , Animals , Cattle/metabolism , Energy Metabolism/drug effects , Female , Fermentation/drug effects , Food Additives/administration & dosage , Fumarates/administration & dosage , Fumarates/pharmacology , Lauric Acids/administration & dosage , Lauric Acids/pharmacology , Linseed Oil/administration & dosage , Linseed Oil/pharmacology , Myristic Acid/administration & dosage , Myristic Acid/pharmacology , Rumen/metabolism
11.
Brain Res ; 1367: 33-42, 2011 Jan 07.
Article in English | MEDLINE | ID: mdl-20970407

ABSTRACT

Identifying small molecules that suppress apoptosis is promising for the therapy of brain diseases. We recently showed that autocrine bone morphogenetic protein (BMP) signaling involves the effects of cholesterol myristate present in traditional Chinese medicine on mesenchymal stem cells. The present study evaluated the effects of cholesterol myristate on the apoptosis and BMP signaling of PC12 cells. PC12 cells transfected by the inhibitor of differentiation (Id1) promoter reporter construct target gene of BMP4 signaling; cholesterol myristate increases the activity of Id1 promoter. However, structurally related steroids such as cholesterol, ß-sitosterol and cholesten-3-one, lack of the myristate, did not affect the activity of Id1 promoter, suggesting that myristate is essential for the effect of cholesterol myristate. These effects depend on BMP signaling. Apoptosis analysis indicated that cholesterol myristate inhibited the apoptosis of PC12 cells induced in serum-free condition. Cholesterol myristate significantly increases the expression of BMP4, BMPRIA, p-Smad1/5/8, Id1 and its antiapoptotic target gene Bcl-xL in PC12 cells treated in serum-free condition. Moreover, BMP antagonist reduced the anti-apoptotic effect of cholesterol myristate. Thus, this study is to provide evidence that BMP-Id pathway targeted by cholesterol myristate suppresses the apoptosis of PC12 cells. Our findings are therefore of considerable therapeutic significance and provide the potential of newly exploiting cholesterol myristate and clinically in brain disease therapies.


Subject(s)
Apoptosis/drug effects , Bone Morphogenetic Protein 4/metabolism , Cholesterol/pharmacology , Inhibitor of Differentiation Protein 1/metabolism , Myristic Acid/pharmacology , Signal Transduction/drug effects , Animals , Antibodies/pharmacology , Bone Morphogenetic Protein 4/immunology , Bone Morphogenetic Protein Receptors/metabolism , Culture Media, Serum-Free/adverse effects , Dose-Response Relationship, Drug , Gene Expression Regulation/drug effects , Myristic Acid/chemistry , PC12 Cells , Promoter Regions, Genetic/drug effects , RNA, Messenger , Rats , Time Factors , Transfection/methods
12.
Br J Nutr ; 102(4): 497-501, 2009 Aug.
Article in English | MEDLINE | ID: mdl-19660150

ABSTRACT

Dietary long-chain PUFA, both n-3 and n-6, have unique benefits with respect to CVD risk. The aim of the present study was to determine the mechanisms by which n-3 PUFA (EPA, DHA) and n-6 PUFA (linoleic acid (LA), arachidonic acid (AA)) relative to SFA (myristic acid (MA), palmitic acid (PA)) alter markers of inflammation and cholesterol accumulation in macrophages (MPhi). Cells treated with AA and EPA elicited significantly less inflammatory response than control cells or those treated with MA, PA and LA, with intermediate effects for DHA, as indicated by lower levels of mRNA and secretion of TNFalpha, IL-6 and monocyte chemoattractant protein-1. Differences in cholesterol accumulation after exposure to minimally modified LDL were modest. AA and EPA resulted in significantly lower MPhi scavenger receptor 1 mRNA levels relative to control or MA-, PA-, LA- and DHA-treated cells, and ATP-binding cassette A1 mRNA levels relative to control or MA-, PA- and LA-treated cells. These data suggest changes in the rate of bidirectional cellular cholesterol flux. In summary, individual long-chain PUFA have differential effects on inflammatory response and markers of cholesterol flux in MPhi which are not related to the n position of the first double bond, chain length or degree of saturation.


Subject(s)
Cholesterol/metabolism , Fatty Acids/pharmacology , Macrophages/metabolism , Analysis of Variance , Arachidonic Acid/pharmacology , Cell Line , Chemokine CCL2/analysis , Docosahexaenoic Acids/pharmacology , Fatty Acids/analysis , Fatty Acids, Omega-3/pharmacology , Fatty Acids, Omega-6/pharmacology , Humans , Inflammation , Interleukin-6/analysis , Linoleic Acid/pharmacology , Macrophages/chemistry , Macrophages/immunology , Myristic Acid/pharmacology , Palmitic Acid/pharmacology , RNA, Messenger/analysis , Reverse Transcriptase Polymerase Chain Reaction , Tumor Necrosis Factor-alpha/analysis
13.
J Microbiol Biotechnol ; 18(9): 1522-8, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18852507

ABSTRACT

The morphogenetic behavior of a tropical marine Yarrowia lipolytica strain on hydrophobic substrates was studied. Media containing coconut oil or palm kernel oil (rich in lauric and myristic acids) prepared in distilled water or seawater at a neutral pH supported 95% of the cells to undergo a transition from the yeast form to the mycelium form. With potassium laurate, 51% of the cells were in the mycelium form, whereas with myristate, 32% were in the mycelium form. However, combinations of these two fatty acids in proportions that are present in coconut oil or palm kernel oil enhanced the mycelium formation to 65%. The culture also produced extracellular lipases during the morphogenetic change. The yeast cells were found to attach to the large droplets of the hydrophobic substrates during the transition, while the mycelia were associated with the aqueous phase. The alkane-grown yeast partitioned more efficiently in the hydrophobic phases when compared with the coconut oil-grown mycelia. A fatty acid analysis of the mycelial form revealed the presence of lauric acid in addition to the long-chain saturated and unsaturated fatty acids observed in the yeast form. The mycelia underwent a rapid transition to the yeast form with n-dodecane, a medium-chain aliphatic hydrocarbon. Thus, the fungus displayed a differential behavior towards the two types of saturated hydrophobic substrates.


Subject(s)
Alkanes/pharmacology , Mycelium/cytology , Plant Oils/pharmacology , Yarrowia/cytology , Yarrowia/drug effects , Culture Media , Hydrophobic and Hydrophilic Interactions , Lauric Acids/pharmacology , Lipase/metabolism , Mycelium/drug effects , Mycelium/growth & development , Myristic Acid/pharmacology , Salinity , Yarrowia/enzymology , Yarrowia/growth & development
14.
Lipids ; 42(8): 717-22, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17564735

ABSTRACT

Cholesterol removal from tissues into HDL depends on the activity of lecithin-cholesterol acyltransferase (LCAT; E.C. 2.3.1.43) that is associated with lower cardiovascular diseases risk. HDL cholesterol concentration and LCAT activity can be modulated by dietary fatty acids. Original data with substrate models have shown a positive effect of myristic acid (MA) on the esterification rate of cholesterol. The purpose of this study was to examine the effect of moderate intakes of MA associated with recommended intake of alpha-linolenic acid (ALA) on LCAT activity in humans. Two experimental diets were tested for 3 months each. Diet 1-MA 1.2% of total energy (TE) and ALA 0.9% TE, diet 2-MA 1.8% and ALA 0.9% TE; a control diet (MA 1.2% and ALA 0.4% TE) was given 3 months before diet 1 and diet 2. The endogenous activity of LCAT was determined at completion of each diet. Compared with the control diet (13.2 +/- 3.1 micromol CE/(L x h)), LCAT activity increased significantly (P < 0.001) with diet 1 (24.2 +/- 3.6 micromol CE/(L x h)) and diet 2 (33.3 +/- 7.4 micromol CE/(L x h)); the increase observed with diet 2 was significantly (P < 0.001) greater than that due to diet 1. These results suggest that ALA (from rapeseed oil, mainly in sn-2 position) and MA (from dairy fat, mainly in sn-2 position) favor LCAT activity, by respective increases of 83 and 38%. When they are supplied together, a complementary effect was observed (average increase of 152%). Moreover, these observations were associated with a decrease of the ratio of total to HDL-cholesterol. In conclusion, our results suggest that moderate supply of MA (1.8% TE) associated with the recommended intake of ALA (0.9% TE) contributes to improve LCAT activity.


Subject(s)
Myristic Acid/administration & dosage , Phosphatidylcholine-Sterol O-Acyltransferase/metabolism , alpha-Linolenic Acid/administration & dosage , Adult , Aged , Aged, 80 and over , Dietary Fats/administration & dosage , Dietary Fats/pharmacology , Humans , Lipids/blood , Lipoproteins/blood , Male , Middle Aged , Myristic Acid/pharmacology , Phosphatidylcholine-Sterol O-Acyltransferase/blood , alpha-Linolenic Acid/pharmacology
15.
J Med Food ; 9(3): 395-9, 2006.
Article in English | MEDLINE | ID: mdl-17004905

ABSTRACT

Nutmeg (Myristica fragrans) is used in food preparations for its aromatic flavor. The present investigation was undertaken to evaluate the antibacterial activity of constituents of M. fragrans seeds. Seeds of M. fragrans were powdered and extracted with chloroform to obtain trimyristin, which on saponification yielded myristic acid. The mother liquor remaining after separation of trimyristin was concentrated and column-chromatographed with petroleum ether to separate myristicin. Antibacterial activity of these isolated constituents was evaluated by determination of minimum inhibitory concentration against selected Gram-positive and Gram-negative organisms. All the constituents isolated from nutmeg exhibited good antibacterial activity. This study shows the potential of natural compounds in replacement of synthetic preservatives.


Subject(s)
Anti-Bacterial Agents/isolation & purification , Myristica/chemistry , Seeds/chemistry , Allylbenzene Derivatives , Anti-Bacterial Agents/pharmacology , Benzyl Compounds/isolation & purification , Benzyl Compounds/pharmacology , Chloroform , Dioxolanes/isolation & purification , Dioxolanes/pharmacology , Gram-Negative Bacteria/drug effects , Gram-Positive Bacteria/drug effects , Myristic Acid/isolation & purification , Myristic Acid/pharmacology , Plant Extracts/chemistry , Pyrogallol/analogs & derivatives , Pyrogallol/isolation & purification , Pyrogallol/pharmacology , Triglycerides/isolation & purification , Triglycerides/pharmacology
16.
J Anim Physiol Anim Nutr (Berl) ; 89(7-8): 284-96, 2005 Aug.
Article in English | MEDLINE | ID: mdl-15972079

ABSTRACT

In a 6 x 6 Latin square arrangement, sheep of 41 kg body weight were fed myristic acid [C14:0; 50 g/kg dry matter (DM)] supplemented to two basal diets of forage : concentrate ratios of 1 : 1.5 and 1 : 0.5 and adjusted to dietary calcium (Ca) contents of either 4.2 or 9.0 g/kg DM (the latter only together with C14:0 supplementation). Various variables of energy, fatty acid and Ca metabolism were determined in combined digestibility and respiratory chamber measurements. With C14:0 addition the energy loss via the faeces increased (p < 0.05, post hoc test) without affecting energy digestibility of the complete diet. The apparent digestibility of supplemented C14:0 was higher (p < 0.01) with approximately 0.8 in the forage-based diet than in the concentrate-based diet (approximately 0.6). The elevated levels of plasma C14:0 were mainly accompanied by reduced C18:0 and C18:1 levels. The estimated apparent content of metabolizable energy (ME) of added C14:0 was either 24.5 MJ/kg (concentrate-based diet) or 32.1 MJ/kg (forage-based diet). Extra Ca equalized these differences between basal diets and ME contents amounted to 33.0 MJ/kg on average. As expected from corresponding slight shifts in energy metabolizability, the total efficiency of ME utilization increased (p < 0.1) with C14:0. The lower level of dietary Ca was still within the range recommended, but adding C14:0 to the concentrate-based diet reduced Ca retention in the body of the sheep from 0.9 to -0.1 g/day because of an impaired (p < 0.05, post hoc test) net Ca absorption, whereas no effect was found with the forage-based diet. With C14:0 addition, plasma total phosphorus (P) and serum calcitrol levels increased (p < 0.05, post hoc test) while Ca concentrations did not clearly reflect the reduced net Ca absorption. Increasing the dietary Ca content prevented adverse effects on Ca retention in the concentrate-based diet and improved Ca retention in the forage-based diet. In conclusion, the C14:0 supplementation reduced Ca availability in concentrate-based diets while an additional supply of Ca improved Ca and energy retention. Consequently, Ca supply should exceed recommended levels in diet types where dietary lipids are likely to reduce Ca availability and a compromise in basal diet type has to found to be able to profit best from the energetic value and the methane-suppressing properties of C14:0.


Subject(s)
Calcium, Dietary/pharmacokinetics , Calcium/metabolism , Energy Metabolism/drug effects , Fatty Acids/metabolism , Myristic Acid/administration & dosage , Sheep/metabolism , Animal Feed , Animal Nutritional Physiological Phenomena , Animals , Biological Availability , Calcium, Dietary/administration & dosage , Dietary Supplements , Dose-Response Relationship, Drug , Energy Metabolism/physiology , Fatty Acids/blood , Intestinal Absorption , Male , Myristic Acid/blood , Myristic Acid/pharmacology , Random Allocation
17.
Br J Nutr ; 92(4): 689-700, 2004 Oct.
Article in English | MEDLINE | ID: mdl-15522139

ABSTRACT

The interactions of lauric (C12) and myristic acid (C14) in suppressing ruminal methanogenesis and methanogens were investigated with the rumen simulation technique (Rusitec) using bovine ruminal fluid. The fatty acids were added to basal substrates (grass hay:concentrate, 1:1.5) at a level of 48 g/kg DM, provided in C12:C14 ratios of 5:0, 4:1, 3:2, 2.5:2.5, 2:3, 1:4 and 0:5. Additionally, an unsupplemented control consisting of the basal substrates only was employed. Incubation periods lasted for 15 (n 4) and 25 (n 2) d. CH4 formation was depressed by any fatty acid mixture containing at least 40 % C12, and effects persisted over the complete incubation periods. The greatest depression (70 % relative to control) occurred with a C12:C14 ratio of 4:1, whereas the second most effective treatment in suppressing CH4 production (60 % relative to control) was found with a ratio of 3:2. Total methanogenic counts were decreased by those mixtures of C12 and C14 also successful in suppressing methanogenesis, the 4:1 treatment being most efficient (60 % decline). With this treatment in particular, the composition of the methanogenic population was altered in such a way that the proportion of Methanococcales increased and Methanobacteriales decreased. Initially, CH4 suppression was associated with a decreased fibre degradation, which, however, was reversed after 10 d of incubation. The present study demonstrated a clear synergistic effect of mixtures of C12 and C14 in suppressing methanogenesis, mediated probably by direct inhibitory effects of the fatty acids on the methanogens.


Subject(s)
Dietary Supplements , Lauric Acids/pharmacology , Methane/metabolism , Myristic Acid/pharmacology , Rumen/metabolism , Animal Feed , Animals , Cattle , Drug Synergism , Fermentation/drug effects , Rumen/microbiology
18.
J Bioenerg Biomembr ; 36(3): 241-8, 2004 Jun.
Article in English | MEDLINE | ID: mdl-15337854

ABSTRACT

The inner membrane of freshly isolated mammalian mitochondria is poorly permeable to Cl(-). Low, nonlytic concentrations (< or =30 microM) of long-chain fatty acids or their branched-chain derivatives increase permeation of Cl(-) as indicated from rapid large-scale swelling of mitochondria suspended in slightly alkaline KCl medium (supplemented with valinomycin). Myristic, palmitic, or 5-doxylstearic acid are powerful inducers of Cl(-) permeation, whereas lauric, phytanic, stearic, or 16-doxylstearic acid stimulate Cl(-) permeation in a lesser extent. Fatty acid-induced Cl(-) permeation across the inner membrane correlates well with the property of nonesterified fatty acids to release endogenous Mg(2+) from mitochondria. Myristic acid stimulates anion permeation in a selective manner, similar as was described for A23187, an activator of the inner membrane anion channel (IMAC). Myristic acid-induced Cl(-) permeation is blocked by low concentrations of tributyltin chloride (IC(50) approximately 1.5 nmol/mg protein). Moreover, myristic acid activates a transmembrane ion current in patch-clamped mitoplasts (mitochondria with the outer membrane removed) exposed to alkaline KCl medium. This current is best ascribed to the opening of an ion channel with a single-channel conductance of 108 pS. We propose that long-chain fatty acids can activate IMAC by withdrawal of Mg(2+) from intrinsic binding sites.


Subject(s)
Antiporters/metabolism , Chlorides/metabolism , Fatty Acids/pharmacology , Intracellular Membranes/drug effects , Liver/metabolism , Mitochondria/metabolism , Animals , Fatty Acids/metabolism , Hydrogen-Ion Concentration , Intracellular Membranes/metabolism , Magnesium/metabolism , Membrane Potentials/drug effects , Mitochondrial Swelling/physiology , Myristic Acid/pharmacology , Patch-Clamp Techniques , Rats , Spectrophotometry
19.
Res Exp Med (Berl) ; 199(4): 195-206, 2000 Feb.
Article in English | MEDLINE | ID: mdl-10743677

ABSTRACT

Weanling rats fed a methyl-deficient diet develop acute renal failure, the morphological features of which vary from focal tubular necrosis to widespread cortical necrosis. We and others have shown that coconut oil, rich in saturated fatty acids, has a renal protective effect in this experimental model. In the experiment we are reporting now, we studied which fatty acid is involved in the protection afforded by coconut oil by feeding five groups of methyl-deficient rats a mixture of corn oil and hydrogenated vegetable oil, C6-C8-C10 fatty acids, C12 fatty acid, C14 fatty acid and C16-C18 fatty acids. Five groups of rats receiving the same diets supplemented with choline chloride were used as controls. The group of methyl-deficient rats fed C14 fatty acid (myristic acid) showed a greater percentage of surviving animals and lower renal damage than the other groups of methyl-deficient rats, indicating that the protective effect of coconut oil found in previous experiments is due to its high content of myristic acid.


Subject(s)
Choline Deficiency/complications , Diet , Kidney Cortex Necrosis/prevention & control , Myristic Acid/pharmacology , Analysis of Variance , Animals , Body Weight , Choline Deficiency/pathology , Creatinine/blood , Kidney Cortex Necrosis/etiology , Kidney Cortex Necrosis/pathology , Male , Organ Size , Rats , Rats, Wistar , Urea/blood
20.
J Ethnopharmacol ; 68(1-3): 209-17, 1999 Dec 15.
Article in English | MEDLINE | ID: mdl-10624880

ABSTRACT

It is well established that nitric oxide (NO) and superoxide radicals play pivotal roles in the pathogenesis of inflammatory diseases and fever. This study is undertaken to address whether the methanol extract of Spiraea prunifolia var. simpliciflora root, a traditional medicine as an antipyretic, modulates the generation of NO and superoxide in IFN-gamma primed or polymyristic acetate (PMA) stimulated RAW 264.7 cells, respectively. The generation of NO as well as the expression of inducible nitric oxide synthase (iNOS) protein from IFN-gamma primed RAW 264.7 cells is markedly decreased by the methanol extract in a dose dependent manner. However, the methanol extract does not affect the viability of RAW 264.7 cells, as assessed by methylthiazol-2-yl-2,5-diphenyl tetrazolium bromide (MTT) assay. In addition, the methanol extract suppresses the generation of superoxide in PMA-stimulated RAW 264.7 cells in a dose and a time dependent manner. Taken together, anti-pyretic effects of Spiraea prunifolia var. simpliciflora root extract could result from direct suppression of NO and decreased superoxide generation.


Subject(s)
Cell Survival/drug effects , Macrophages/drug effects , Macrophages/metabolism , Nitric Oxide/biosynthesis , Plant Extracts/pharmacology , Plant Roots/chemistry , Superoxides/metabolism , Analgesics, Non-Narcotic/pharmacology , Animals , Blotting, Western , Cells, Cultured , Dose-Response Relationship, Drug , Interferon-gamma/pharmacology , Medicine, Traditional , Methanol/chemistry , Mice , Myristic Acid/pharmacology , Nitric Oxide Synthase/drug effects , Nitric Oxide Synthase/metabolism , Nitric Oxide Synthase Type II , Solubility , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL